Total Payments
$7,753
2023 Payments
$63.14
Companies
44
Transactions
602
Medicare Patients
2,006
Medicare Billing
$133,846
Payment Breakdown by Category
Food & Beverage$7,743 (99.9%)
Education$9.90 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,743 | 600 | 99.9% |
| Education | $9.90 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $855.79 | 57 | $0 (2021) |
| PFIZER INC. | $800.02 | 77 | $0 (2023) |
| Lilly USA, LLC | $679.49 | 65 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $610.25 | 49 | $0 (2021) |
| ABBVIE INC. | $595.67 | 56 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $531.52 | 36 | $0 (2021) |
| Allergan, Inc. | $382.00 | 30 | $0 (2020) |
| GlaxoSmithKline, LLC. | $318.92 | 21 | $0 (2021) |
| Amarin Pharma Inc. | $291.18 | 21 | $0 (2021) |
| Novo Nordisk Inc | $209.70 | 14 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $63.14 | 3 | PFIZER INC. ($63.14) |
| 2022 | $33.61 | 2 | ABBVIE INC. ($17.83) |
| 2021 | $1,152 | 74 | AbbVie Inc. ($249.67) |
| 2020 | $1,026 | 71 | AstraZeneca Pharmaceuticals LP ($166.91) |
| 2019 | $1,409 | 121 | PFIZER INC. ($195.50) |
| 2018 | $1,662 | 136 | PFIZER INC. ($246.22) |
| 2017 | $2,408 | 195 | AstraZeneca Pharmaceuticals LP ($242.29) |
All Payment Transactions
602 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/16/2023 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: VACCINES | ||||||
| 04/06/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: VACCINES | ||||||
| 02/08/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: VACCINES | ||||||
| 11/16/2022 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: VACCINES | ||||||
| 01/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Gastroenterology | ||||||
| 12/14/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2021 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: VACCINES | ||||||
| 12/03/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Diabetes | ||||||
| 11/30/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Cardiovascular | ||||||
| 11/17/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/17/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Gastroenterology | ||||||
| 11/15/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/08/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Cardio-renal | ||||||
| 11/06/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Neuroscience | ||||||
| 10/25/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Virology & Specialty Care | ||||||
| 10/20/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Cardio-renal | ||||||
| 10/19/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $0.61 | General |
| Category: Cardio-renal | ||||||
| 10/18/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/18/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/14/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 15 | 992 | 1,541 | $170,779 | $68,207 |
| 2020 | 13 | 1,014 | 1,674 | $191,349 | $65,639 |
Total Patients
2,006
Total Services
3,215
Medicare Billing
$133,846
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 201 | 365 | $62,780 | $28,988 | 46.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 114 | 114 | $38,874 | $14,701 | 37.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 156 | 228 | $25,308 | $13,292 | 52.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 25 | 25 | $12,800 | $3,930 | 30.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 29 | 29 | $2,030 | $1,762 | 86.8% |
| 87428 | Sarscov & inf vir a&b ag ia | Office | 2021 | 17 | 19 | $4,883 | $1,396 | 28.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 197 | 323 | $5,814 | $969.00 | 16.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 80 | 82 | $6,560 | $733.43 | 11.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 31 | 31 | $2,449 | $694.76 | 28.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 34 | 74 | $4,662 | $649.58 | 13.9% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 12 | 12 | $1,920 | $542.76 | 28.3% |
| 87880 | Strep test by immunoassay for streptococcus | Office | 2021 | 12 | 12 | $600.00 | $198.36 | 33.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 28 | 168 | $1,680 | $140.39 | 8.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 28 | 28 | $140.00 | $140.00 | 100.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 28 | 31 | $279.00 | $69.75 | 25.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 232 | 459 | $78,948 | $30,460 | 38.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 119 | 119 | $40,579 | $13,386 | 33.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 155 | 215 | $23,865 | $9,663 | 40.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 37 | 37 | $18,944 | $6,128 | 32.3% |
| 87426 | Coronavirus ag ia | Office | 2020 | 23 | 26 | $4,160 | $1,176 | 28.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 210 | 377 | $6,786 | $1,123 | 16.6% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 18 | 18 | $1,080 | $1,044 | 96.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 87 | 90 | $7,200 | $829.45 | 11.5% |
| 87804 | Detection test for influenza virus | Office | 2020 | 24 | 47 | $2,350 | $765.31 | 32.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 36 | 89 | $5,607 | $752.23 | 13.4% |
About Dr. Kye Lear, MD
Dr. Kye Lear, MD is a Family Medicine healthcare provider based in Lubbock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255394094.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kye Lear, MD has received a total of $7,753 in payments from pharmaceutical and medical device companies, with $63.14 received in 2023. These payments were reported across 602 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($7,743).
As a Medicare-enrolled provider, Lear has provided services to 2,006 Medicare beneficiaries, totaling 3,215 services with total Medicare billing of $133,846. Data is available for 2 years (2020–2021), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lubbock, TX
- Active Since 04/11/2006
- Last Updated 05/11/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1255394094
Products in Payments
- FARXIGA (Drug) $438.26
- JANUVIA (Drug) $366.84
- TRULICITY (Drug) $353.83
- JARDIANCE (Drug) $330.34
- Vascepa (Drug) $291.18
- SYMBICORT (Drug) $262.36
- ELIQUIS (Drug) $247.88
- LYRICA (Drug) $239.99
- VRAYLAR (Drug) $202.75
- LINZESS (Drug) $191.70
- BEVESPI AEROSPHERE (Drug) $155.17
- TOVIAZ (Drug) $144.03
- CONTRAVE (Drug) $136.75
- NUEDEXTA (Drug) $133.05
- BELSOMRA (Drug) $131.09
- XIFAXAN (Drug) $126.33
- STIOLTO RESPIMAT (Drug) $123.46
- NURTEC ODT (Drug) $122.77
- Xofluza (Drug) $120.88
- TRADJENTA (Drug) $116.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lubbock
Dr. Michael Mendez, M.d, M.D
Family Medicine — Payments: $273,840
Family Medicine $273,840
Dr. Robert Ordonez, M.d, M.D
Family Medicine — Payments: $22,971
Family Medicine $22,971
Samuel Hale
Family Medicine — Payments: $13,773
Family Medicine $13,773
Randy Rozean, Md, MD
Family Medicine — Payments: $13,047
Family Medicine $13,047
Joel Landry, Md, MD
Family Medicine — Payments: $12,105
Family Medicine $12,105
Dr. Craig Barker, Md, MD
Family Medicine — Payments: $12,094
Family Medicine $12,094